Stay updated on Avutometinib and Defactinib in Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    New and removed entry dates were added to the study record, with the latest update posted on 2026-03-27.
    Difference
    0.2%
    Check dated 2026-04-02T15:32:56.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision log updated: v3.5.0 added and v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:25:03.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added and v3.4.2 has been removed, updating the page’s revision label.
    Difference
    0.1%
    Check dated 2026-03-12T02:55:52.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Study locations updated to 7 sites. Some site contacts and location details were removed (e.g., Allentown, PA / Lehigh Valley contact information).
    Difference
    0.7%
    Check dated 2026-02-25T21:19:55.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page; the government funding lapse notice and related operating-status banner were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:47:53.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page now displays a site-wide notice about a lapse in government funding and shows the site revision to v3.4.1, replacing v3.4.0. These changes are administrative and do not affect the study details, eligibility criteria, or outcomes.
    Difference
    0.4%
    Check dated 2026-02-04T10:29:47.000Z thumbnail image

Stay in the know with updates to Avutometinib and Defactinib in Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.